These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20860853)

  • 21. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
    Carr AC; Shaw GM; Fowler AA; Natarajan R
    Crit Care; 2015 Nov; 19():418. PubMed ID: 26612352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction.
    Ducrocq N; Kimmoun A; Furmaniuk A; Hekalo Z; Maskali F; Poussier S; Marie PY; Levy B
    Anesthesiology; 2012 May; 116(5):1083-91. PubMed ID: 22407285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasopressor for refractory septic shock: dexmedetomidine could help decrease norepinephrine requirements.
    Dargent A; Quintin L; Jacquier M; Fournel I; Quenot JP
    Minerva Anestesiol; 2020 Aug; 86(8):885-886. PubMed ID: 32538581
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock.
    Vadiei N; Daley MJ; Murthy MS; Shuman CS
    Ann Pharmacother; 2017 Mar; 51(3):194-202. PubMed ID: 27886982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selepressin, a novel selective vasopressin V
    Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
    Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.
    Albanèse J; Leone M; Delmas A; Martin C
    Crit Care Med; 2005 Sep; 33(9):1897-902. PubMed ID: 16148457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasopressor weaning in patients with septic shock.
    Arellano DL; Hanneman SK
    Crit Care Nurs Clin North Am; 2014 Sep; 26(3):413-25. PubMed ID: 25169693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
    Russell JA; Lee T; Singer J; De Backer D; Annane D
    J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of norepinephrine on the outcome of septic shock.
    Martin C; Viviand X; Leone M; Thirion X
    Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial.
    Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Laderchi A; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
    Crit Care; 2008; 12(6):R143. PubMed ID: 19017409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radial artery pressure monitoring underestimates central arterial pressure during vasopressor therapy in critically ill surgical patients.
    Dorman T; Breslow MJ; Lipsett PA; Rosenberg JM; Balser JR; Almog Y; Rosenfeld BA
    Crit Care Med; 1998 Oct; 26(10):1646-9. PubMed ID: 9781720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenergic vasopressor agents and mechanical ventilation for the treatment of experimental septic shock.
    Tang W; Pakula JL; Weil MH; Noc M; Fukui M; Bisera J
    Crit Care Med; 1996 Jan; 24(1):125-30. PubMed ID: 8565517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of short-term vasopressin infusion during severe septic shock.
    Patel BM; Chittock DR; Russell JA; Walley KR
    Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
    Rehberg S; Enkhbaatar P; Traber DL
    Crit Care; 2009; 13(4):178. PubMed ID: 19691818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practice Patterns and Outcomes Associated With Choice of Initial Vasopressor Therapy for Septic Shock.
    Fawzy A; Evans SR; Walkey AJ
    Crit Care Med; 2015 Oct; 43(10):2141-6. PubMed ID: 26079345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
    Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose vasopressin is not superior to norepinephrine in septic shock.
    Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
    Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
    Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
    J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
    Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
    Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock.
    Chotalia M; Matthews T; Arunkumar S; Bangash MN; Parekh D; Patel JM
    Anaesthesia; 2021 Oct; 76(10):1358-1366. PubMed ID: 33687732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.